Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Verovaccines logo — VEROVACCiNES creates affordable animal vaccines through inno...

Verovaccines

VEROVACCiNES creates affordable animal vaccines through innovative technology, with the ability to combine multiple antigens in one vaccine.

Founded 2017 2-10 employees Series B Total: $3.10M Biotechnology, Health Care +1

General Information

Company Name Verovaccines
Founded Year 2017
Employees 2-10
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series B
Social

Get notified when Verovaccines moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Verovaccines

Verovaccines is a biotechnology startup dedicated to creating affordable animal vaccines through innovative technology, with the ability to combine multiple antigens in one vaccine. The company's proprietary technology offers an effective and economical means of developing vaccines, reducing immunization effort, and minimizing antibiotic use. With a focus on improving animal health, Verovaccines' latest breakthrough allows for the integration of multiple antigens into a single vaccine without increasing production costs. This advancement paves the way for the creation of vaccines that can target multiple pathogens or provide immunity to various strains of the same pathogen. Established in 2017, the startup has developed five vaccine programs, with four of them having already achieved proof of concept. The pipeline includes several candidates with the potential to become blockbusters, offering comprehensive solutions for the poultry, swine, and ruminant industries. Verovaccines' most recent Series B investment on 14 October 2021 was secured from the German Federal Ministry of Education and Research, demonstrating confidence in the company's potential within the biotechnology, health care, and pharmaceutical sectors.

Taxonomy: Animal Vaccines, Innovative Technology, Subunit Marker Vaccines, Multivalent Vaccines, Cost-Effective Manufacturing, Combination Vaccine, Thermostability, IP, Veterinary Pharmaceuticals, Collaborations

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1 •••• •••• 14 Oct 2021
Seed Round •••••• 3 •••• •••• 03 Dec 2019
Grant •••••• 1 •••• •••• 17 Apr 2018

Verovaccines Alternatives & Competitors

Verovaccines vs
Valneva
Valneva France

Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such a...

Grant
637 employees
Biotechnology, Health Care
Compare Verovaccines vs Valneva
Verovaccines vs
Mazen Animal Health - Oral Vaccines
Mazen Animal Health - Oral Vaccines United States

Game-changing animal disease prevention with orally-delivered, RT stable, cost effective vaccines fo...

Series A
21 employees
Biotechnology, Health Care
Verovaccines vs
Vaxart, Inc.
Vaxart, Inc. United States

The pill that moves the needle.

IPO
108 employees
Biotechnology, Health Care

FAQ About Verovaccines

VEROVACCiNES creates affordable animal vaccines through innovative technology, with the ability to combine multiple antigens in one vaccine.
Verovaccines was founded in 2017.
Verovaccines operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Verovaccines has approximately 2-10 employees.
Verovaccines has completed 3 funding rounds, raising a total of $3.10M. The latest funding stage is Series B.
Top alternatives and competitors to Verovaccines include Valneva, Mazen Animal Health - Oral Vaccines, Vaxart, Inc., Bharat Biotech, Walvax. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Verovaccines and Valneva are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Verovaccines and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy